- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 08.07. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | Glucotrack, Inc.: Glucotrack Announces Repurchase of Series A Warrants | 1 | GlobeNewswire (USA) | ||
| 27.06. | Pre-market Movers: Blue Gold, INmune Bio, Cyngn, NanoVibronix, GlucoTrack | 656 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.20 A.M. ET).In the Green Blue Gold Limited (BGL) is up over 297% at $80.01.
INmune... ► Artikel lesen | |
| 25.06. | GlucoTrack Stock Jumps 40% On Strong Clinical Data For Implantable Glucose Monitor | 2 | RTTNews | ||
| 25.06. | Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday? | 3 | Benzinga.com | ||
| 25.06. | Glucotrack reports positive results from first human trial of blood glucose monitor | 3 | Investing.com | ||
| 25.06. | Glucotrack berichtet über positive Ergebnisse der ersten klinischen Studie am Menschen | 2 | Investing.com Deutsch | ||
| 25.06. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.06. | A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology | 1 | MassDevice | ||
| 12.06. | Glucotrack announces 1-for-60 reverse stock split effective June 16 | 2 | Investing.com | ||
| 12.06. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12.06. | GlucoTrack, Inc.: Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements | 237 | GlobeNewswire (Europe) | 1-for-60 reverse stock split to become effective as of the opening of trading on June 16, 2025 Rutherford, NJ, June 12, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the... ► Artikel lesen | |
| 04.06. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 04.06. | Glucotrack, Inc.: Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions | 1 | GlobeNewswire (USA) | ||
| 28.05. | Glucotrack appoints new board member with diabetes tech expertise | 1 | Investing.com | ||
| 28.05. | Glucotrack, Inc.: Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD | 14 | GlobeNewswire (USA) | ||
| 20.05. | Glucotrack, Inc.: Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development | 1 | GlobeNewswire (USA) | ||
| 20.05. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 15.05. | Glucotrack GAAP EPS of -$0.67 | 1 | Seeking Alpha | ||
| 14.05. | Glucotrack, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings |
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 66,55 | +1,29 % | Eckert&Ziegler mit KURSCRASH-GEFAHR? Experten schlagen Alarm - jetzt zählt jede Minute! | ||
| SERNOVA BIOTHERAPEUTICS | 0,106 | +3,92 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| SYNLAB | 12,848 | -100,00 % | Schock-News für Synlab Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
| NUGEN MEDICAL DEVICES | 0,040 | +4,19 % | Beaking News: Vive la InsuJet - mit der Krankenkasse zum Erfolg? | ||
| ATOSSA THERAPEUTICS | 0,796 | -0,25 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,014 | -0,49 % | PA GOODDOCTOR (01833): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | ||
| UNIDOC HEALTH | 0,110 | -6,77 % | UniDoc Health Corp. kündigt Teilnahme an der Ukraine Recovery Conference (URC2025) an | - UniDoc wird auf der internationalen Veranstaltung in Rom (Italien) seine laufenden humanitären und innovativen Bemühungen im Gesundheitswesen
präsentieren
VANCOUVER,... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Windtree Therapeutics: Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel | Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,210 | -0,94 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| CYTOSORBENTS | 0,904 | -0,77 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
| VERU | 0,508 | -0,97 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
| QUIDELORTHO | 26,600 | +2,31 % | QuidelOrtho Corporation: QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs | New executives bring deep expertise to elevate quality and accelerate innovation across global operations SAN DIEGO, July 7, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL)... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 144,25 | +0,31 % | Dividendenbekanntmachungen (07.07.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALIMENTATION COUCHE-TARD INC CA01626P1484 0,195 CAD 0,1217 EUR ALTAREA SCA FR0000033219 - EUR CHINA DATANG CORPORATION RENEWABLE... ► Artikel lesen |
Das Unternehmen GLUCOTRACK INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 5,650 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.